Offer - Urjas Oil for just ₹ 1 X
Uniphos 200 Injection, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Ovarian Cancer, Multiple Myeloma. The alternative uses of Uniphos 200 Injection have also been explained below.
The optimal dosage of Uniphos 200 Injection is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Uniphos 200 Injection as well, which are listed below. Normally, these side effects of Uniphos 200 Injection are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Uniphos 200 Injection's effect is Severe during pregnancy and Severe for lactating mothers. Further, the section on Uniphos 200 Injection related warnings talks about Uniphos 200 Injection's effects on the liver, heart and kidney.
The section on Uniphos 200 Injection contraindications lists all such conditions.
Drug reaction of Uniphos 200 Injection with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Uniphos 200 Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Uniphos 200 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Adult |
|
Is the use of Uniphos 200 Injection safe for pregnant women?
Uniphos should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Uniphos 200 Injection safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Uniphos. It should only be taken after medical advice.
What is the effect of Uniphos 200 Injection on the Kidneys?
Uniphos has very mild side effects on the kidneys.
What is the effect of Uniphos 200 Injection on the Liver?
Uniphos may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Uniphos 200 Injection on the Heart?
Very few cases of side effects of Uniphos on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Uniphos 200 Injection unless your doctor advises you to do so -
Is this Uniphos 200 Injection habit forming or addictive?
No, you will not get addicted to Uniphos 200 Injection.
Is it safe to drive or operate heavy machinery when consuming?
After taking Uniphos 200 Injection, you should not drive or work on any heavy machine, as Uniphos 200 Injection can make you drowsy.
Is it safe?
Yes, but take Uniphos 200 Injection only as per medical advice.
Is it able to treat mental disorders?
No, Uniphos 200 Injection cannot treat any kind of mental disorder.
Interaction between Food and Uniphos 200 Injection
Taking Uniphos 200 Injection with food does not harm your health.
Interaction between Alcohol and Uniphos 200 Injection
Information about the interaction of Uniphos 200 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyclophosphamide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 860
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 375-377